Odrel® Plus is a fixed dose combination containing Clopidogrel and Aspirin.Clopidogrel is an inhibitor of platelet aggregation. Clopidogrel selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet receptor and the subsequent ADP-mediated activation of the glycoprotein GP Complex, thereby inhibiting platelet aggregation.Aspirin is also an antiplatelet agent. It acts by causing irreversible inhibition of the cyclo-oxygenase enzyme, which leads to decreased formation of thromboxane A2. Since platelets do not synthesise new enzyme, the action of Aspirin on platelet cyclo-oxygenase is permanent, lasting for the life of the platelets (7-10 days).Odrel® Plus is indicated for the prevention of ischemic events, myocardial infarction, stroke and cardiovascular death in-patients what acute coronary syndrome.
- Ensures a comprehensive anti platelet action
- Effectively reduces the risk of cerebral ishchemic attack
- Offers a life time risk reduction from cardiovascular events